Abstract
Rutin is a natural anti-inflammatory ingredient widely found in medicinal plants. Studies have shown that rutin inhibits mast cell degranulation and the release of inflammatory mediators. Mast cell P2X7 receptor mediates mast cell degranulation and serves as a therapeutic target for inflammatory pain. Herein, the aim of this study was to investigate whether the anti-inflammatory mechanism of rutin is related to the mast cell P2X7 receptor. Our results showed that rutin could inhibit [Ca2+]i elevation induced by 5 mM ATP or 30 μM BZATP in a concentration-dependent manner in mouse peritoneal mast cells. Rutin also suppressed the inward current mediated by P2X7 receptor. In vivo, rutin could significantly inhibit the mechanical hypersensitivity induced by 100 mM ATP that is associated with P2X7 receptor in mast cells. Moreover, molecular docking revealed the high affinity between rutin and the P2X7 receptor crystal structure. Collectively, this study demonstrated that rutin attenuated inflammatory pain by inhibiting the activity of P2X7 receptor in mast cells.
Similar content being viewed by others
References
Ganeshpurkar A, Saluja AK (2017) The pharmacological potential of rutin. Saudi Pharm J 25:149–164
Arowoogun J, Akanni OO, Adefisan AO, Owumi SE, Tijani AS, Adaramoye OA (2021) Rutin ameliorates copper sulfate-induced brain damage via antioxidative and anti-inflammatory activities in rats. J Biochem Mol Toxicol 35:e22623
Teixeira FM, Coelho MN, Jose-Chagas F, Malvar D, Kanashiro A, Cunha FQ, Machado VM, Da CPA, Vanderlinde FA, Costa SS (2020) Oral treatments with a flavonoid-enriched fraction from Cecropia hololeuca and with rutin reduce articular pain and inflammation in murine zymosan-induced arthritis. J Ethnopharmacol 260:112841
Han Y (2009) Rutin has therapeutic effect on septic arthritis caused by Candida albicans. Int Immunopharmacol 9:207–211
Habtemariam S, Belai A (2018) Natural therapies of the inflammatory bowel disease: the case of rutin and its aglycone, quercetin. Mini Rev Med Chem 18:234–243
Chen X, Yu M, Xu W, Zou L, Ye J, Liu Y, Xiao Y, Luo J (2021) Rutin inhibited the advanced glycation end products-stimulated inflammatory response and extra-cellular matrix degeneration via targeting TRAF-6 and BCL-2 proteins in mouse model of osteoarthritis. Aging (Albany NY) 13:22134–22147
Liu S, Adewole D, Yu L, Sid V, Wang B, Karmin O, Yang C (2019) Rutin attenuates inflammatory responses induced by lipopolysaccharide in an in vitro mouse muscle cell (C2C12) model. Poult Sci 98:2756–2764
Yoo H, Ku SK, Baek YD, Bae JS (2014) Anti-inflammatory effects of rutin on HMGB1-induced inflammatory responses in vitro and in vivo. Inflamm Res 63:197–206
Selloum L, Bouriche H, Tigrine C, Boudoukha C (2003) Anti-inflammatory effect of rutin on rat paw oedema, and on neutrophils chemotaxis and degranulation. Exp Toxicol Pathol 54:313–318
Fikry EM, Hasan WA, Mohamed EG (2018) Rutin and meloxicam attenuate paw inflammation in mice: affecting sorbitol dehydrogenase activity. J Biochem Mol Toxicol 32:22029
Choi SS, Park HR, Lee KA (2021) A comparative study of rutin and rutin glycoside: antioxidant activity, anti-inflammatory effect, effect on platelet aggregation and blood coagulation. Antioxidants (Basel) 10:1696
Dirckx M, Groeneweg G, van Daele PL, Stronks DL, Huygen FJ (2013) Mast cells: a new target in the treatment of complex regional pain syndrome? Pain Pract 13:599–603
Santos FM, Malafaia CA, Simas D, Paulino AB, Muzitano MF, Simas NK, Cruz DE, Amaral A, Leal I (2020) Phenolic compounds from Tocoyena bullata mart (Rubiaceae) with inhibitory activity in mast cells degranulation. Nat Prod Res 34:3295–3298
Borissova P, Valcheva S, Belcheva A (1994) Antiinflammatory effect of flavonoids in the natural juice from Aronia melanocarpa, rutin and rutin-magnesium complex on an experimental model of inflammation induced by histamine and serotonin. Acta Physiol Pharmacol Bulg 20:25–30
Chen S, Gong J, Liu F, Mohammed U (2000) Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation. Immunology 100:471–480
Choi JK, Kim SH (2013) Rutin suppresses atopic dermatitis and allergic contact dermatitis. Exp Biol Med (Maywood) 238:410–417
Jeong HJ, Yoou MS, Han NR, Hwang SY, Yoon KW, Kim HM (2018) The new therapeutic herbal drug HM0601 and its bioactive compound rutin exert potent antiproliferative activities in mast cells. Fundam Clin Pharmacol 32:279–287
Park HH, Lee S, Son HY, Park SB, Kim MS, Choi EJ, Singh TS, Ha JH, Lee MG, Kim JE, Hyun MC, Kwon TK, Kim YH, Kim SH (2008) Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch Pharm Res 31:1303–1311
Green DP, Limjunyawong N, Gour N, Pundir P, Dong X (2019) A mast-cell-specific receptor mediates neurogenic inflammation and pain. Neuron 101:412–420
Jiang Y, Ye F, Du Y, Zong Y, Tang Z (2021) P2X7R in mast cells is a potential target for salicylic acid and aspirin in treatment of inflammatory pain. J Inflamm Res 14:2913–2931
Kurashima Y, Amiya T, Nochi T, Fujisawa K, Haraguchi T, Iba H, Tsutsui H, Sato S, Nakajima S, Iijima H, Kubo M, Kunisawa J, Kiyono H (2012) Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors. Nat Commun 3:1034
McNeil BD, Pundir P, Meeker S, Han L, Undem BJ, Kulka M, Dong X (2015) Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature 519:237–241
Karasawa A, Kawate T (2016) Structural basis for subtype-specific inhibition of the P2X7 receptor. eLife 5:e22153
He Y, Franchi L, Nunez G (2013) TLR agonists stimulate Nlrp3-dependent IL-1beta production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J Immunol 190:334–339
Hu SQ, Hu JL, Zou FL, Liu JP, Luo HL, Hu DX, Wu LD, Zhang WJ (2022) P2X7 receptor in inflammation and pain. Brain Res Bull 187:199–209
Ren K, Torres R (2009) Role of interleukin-1beta during pain and inflammation. Brain Res Rev 60:57–64
Mai L, Liu Q, Huang F, He H, Fan W (2021) Involvement of mast cells in the pathophysiology of pain. Front Cell Neurosci 15:665066
Meloto CB, Ingelmo P, Perez EV, Pitt R, Gonzalez CV, Mohamed N, Sotocinal SG, Bourassa V, Lima LV, Ribeiro-da-Silva A, Mogil JS, Diatchenko L (2021) Mast cell stabilizer ketotifen fumarate reverses inflammatory but not neuropathic-induced mechanical pain in mice. Pain Rep 6:e902
Traina G (2019) Mast cells in gut and brain and their potential role as an emerging therapeutic target for neural diseases. Front Cell Neurosci 13:345
Gupta K, Harvima IT (2018) Mast cell-neural interactions contribute to pain and itch. Immunol Rev 282:168–187
Theoharides TC, Tsilioni I, Bawazeer M (2019) Mast cells, neuroinflammation and pain in fibromyalgia syndrome. Front Cell Neurosci 13:353
Honore P, Donnelly-Roberts D, Namovic MT, Hsieh G, Zhu CZ, Mikusa JP, Hernandez G, Zhong C, Gauvin DM, Chandran P, Harris R, Medrano AP, Carroll W, Marsh K, Sullivan JP, Faltynek CR, Jarvis MF (2006) A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp ther 319:1376–1385
Teixeira JM, Oliveira MC, Parada CA, Tambeli CH (2010) Peripheral mechanisms underlying the essential role of P2X7 receptors in the development of inflammatory hyperalgesia. Eur J Pharmacol 644:55–60
Michel AD, Chambers LJ, Clay WC, Condreay JP, Walter DS, Chessell IP (2007) Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding. Br J Pharmacol 151:103–114
Allsopp RC, Dayl S, Schmid R, Evans RJ (2017) Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120. Sci Rep 7:725
Al-Majmaie S, Nahar L, Rahman MM, Nath S, Saha P, Talukdar AD, Sharples GP, Sarker SD (2021) Anti-MRSA constituents from Ruta chalepensis (Rutaceae) grown in Iraq, and in silico studies on two of most active compounds, chalepensin and 6-hydroxy-rutin 3',7-dimethyl ether. MOLECULES 26:1114
Jaffal SM, Oran SA, Alsalem M (2020) Anti-nociceptive effect of Arbutus andrachne L. methanolic leaf extract mediated by CB1, TRPV1 and PPARs in mouse pain models. Inflammopharmacology 28:1567–1577
Alonso-Castro AJ, Rangel-Velazquez JE, Isiordia-Espinoza MA, Villanueva-Solis LE, Aragon-Martinez OH, Zapata-Morales JR (2017) Synergism between naproxen and rutin in a mouse model of visceral pain. Drug Dev Res 78:184–188
Carvalho TT, Mizokami SS, Ferraz CR, Manchope MF, Borghi SM, Fattori V, Calixto-Campos C, Camilios-Neto D, Casagrande R, Verri WJ (2019) The granulopoietic cytokine granulocyte colony-stimulating factor (G-CSF) induces pain: analgesia by rutin. Inflammopharmacology 27:1285–1296
Acknowledgements
We thank all participants for their cheerful support.
Funding
The study was financially supported by the National Natural Science Foundation of China (No. 31771163), the Key Project of Jiangsu Administration of Traditional Chinese Medicine (No. ZD202001), and Innovative Project of postgraduate education in Jiangsu Province (No. KYCX21_1745).
Author information
Authors and Affiliations
Contributions
Fan Ye: methodology, performed the experiment, writing—original draft. Material preparation was performed by Jiahua Lv, Xinyu Shen, and Jian Zhang. Yingxin Zong, Chan Zhu, Yan Yang, and Keke Jia collected and analyzed the data. Yucui Jiang: methodology, validation, supervision. Zongxiang Tang: project administration, funding acquisition. The authors declare that all data were generated in-house and that no paper mill was used.
Corresponding authors
Ethics declarations
Ethics approval
The Experimental Animal Ethics Committee of Nanjing University of Chinese Medicine approved the development of this animal experiment. All animal experiments conformed to the Guidelines for the Care and Use of Laboratory Animals and were approved by the Animal Ethics Committee of Nanjing University of Chinese Medicine (Ethics license ACU190601, 20,190,605).
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key points
• Rutin inhibited intracellular calcium mobilization mediated by the P2X7 receptor.
• Rutin inhibited currents mediated by the P2X7 receptor.
• Rutin ameliorated inflammation pain mediated by the P2X7 receptor in mast cells.
Supplementary information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ye, F., Lv, J., Shen, X. et al. Rutin ameliorates inflammatory pain by inhibiting P2X7 receptor in mast cells. J Physiol Biochem 79, 287–295 (2023). https://doi.org/10.1007/s13105-022-00938-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-022-00938-w